Lung Neoplasms: all 7,334 studies
Page 36 of 74. Open to participants first (1,555), then studies with results posted, then the rest; newest registration first within each.
- Remote Monitoring in Cancer Care: A Platform StudyCompletedNCT05018208
- Aurora Kinase Inhibitor LY3295668 in Combination With Osimertinib for the Treatment of Advanced or Metastatic EGFR-Mutant Non-squamous Non-small Cell Lung CancerCompletedNCT05017025Phase 1/2
- Inetetamab in Combination With Pyrotinib in HER2 Mutant or Amplified Advanced Non-small Cell Lung CancerStatus unknownNCT05016544Phase 1/2
- Alectinib in Neo-adjuvant Treatment of Stage III NSCLCActive, not recruitingNCT05015010Phase 2
- Feasibility of a Hybrid Delivery of Home-based Cluster Set Resistance Training in Lung CancerCompletedNCT05014035Not applicable
- Dose Escalation and Expansion Study of SAR443216 in Participants With Relapsed/Refractory HER2 Expressing Solid TumorsTerminatedNCT05013554Phase 1
- Nivolumab and Ipilimumab Plus Chemotherapy for Patients With Stage IV Lung Cancer With Brain MetastasesActive, not recruitingNCT05012254Phase 2
- Identify Prognostic Biomarkers of Lung CancerStatus unknownNCT05010330
- Anti-SARS-COV2 Vaccination Study in Lung Cancer PatientsCompletedNCT05009030
- Gut Microbiota Reconstruction for NSCLC ImmunotherapyStatus unknownNCT05008861Phase 1
- Befotertinib and Icotinib in Treatment-naive Patients With Advanced EGFR-Mutant Lung CancerActive, not recruitingNCT05007938Phase 2
- Ramucirumab, Atezolizumab and N-803 After Progression on Any Immune Checkpoint Blocker in NSCLCWithdrawnNCT05007769Phase 2
- KN046 Plus Lenvatinib in Subject With Advanced Non-Small Cell Lung Cancer in the Failure of Anti-PD-(L)1 AgentTerminatedNCT05001724Phase 2/3
- Chemotherapy Combined With Camrelizumab and Apatinib in First-line Treatment of ES-SCLCStatus unknownNCT05001412Phase 1
- Study of JS004 Combined With Toripalimab for Advanced Lung CancerCompletedNCT05000684Phase 1/2
- FRAME-001 Personalized Vaccine in NSCLCStatus unknownNCT04998474Phase 2
- Chemotherapy Combined with ICIs in First-line Alectinib Failed Patients with ALK-rearranged NSCLCCompletedNCT04997382Phase 2
- Feasibility of Mobile-CT-Assisted Bronchoscopy for the Diagnosis of Lung LesionCompletedNCT04995172
- Predictive Multimodal Signatures Associated With Response to Treatment and Prognosis of Patients With Stage IV Non-small Cell Lung CancerActive, not recruitingNCT04994795
- AP-L1898 Capsule in Patients With Non-small Cell Lung CancerTerminatedNCT04993391Phase 1/2
- PD-L1 Expression in Lung CancerStatus unknownNCT04992715Phase 2
- Adoptive TKC Transfer Combined With Chemotherapy for Advanced Non-small Cell Lung Cancer (NSCLC)Status unknownNCT04990063Phase 1
- Pembrolizumab, Lenvatinib and Chemotherapy After TKIs in NSCLCStatus unknownNCT04989322Phase 2
- Testing the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy Treatment During Radiation Therapy for Superior Sulcus Non-small Cell Lung CancerWithdrawnNCT04989283Phase 2
- Robotic Bronchoscopy With Cone CT and Indocyanine Green to Aid Removal of Lung Lesions in Patients With Stage I Non-small Cell Lung Cancer or Lung Metastases, REPLACING StudyWithdrawnNCT04987281Phase 2
- NutriCare Plus a Medically Tailored Meal Intervention Among Patients With Lung CancerActive, not recruitingNCT04986670Not applicable
- To Evaluate the Efficacy of Durvalumab + Anlotinib in Terms of OS and PFS.Active, not recruitingNCT04985851Not applicable
- Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to DrugsWithdrawnNCT04985357
- Combined Simvastatin and Irinotecan in Treating ES-SCLC Patients Relapsed From 1st ChemotherapyStatus unknownNCT04985201Phase 2
- Construction of CT Radiomics Model for Predicting the Efficacy of Immunotherapy in Patients With Stage III NSCLCStatus unknownNCT04984148
- Women Helping Women - Lung Cancer ScreeningCompletedNCT04983134Not applicable
- Treatment of EGFR-TKI for Residual Lesions of Multiple Synchronous Ground-glass OpacitiesStatus unknownNCT04982900Phase 2
- Multi-dimensional Signatures for Precisely Predicting the Response and Prognosis of Lung Cancer PatientsStatus unknownNCT04980352
- Emergency Department Lung Cancer URMFG PilotCompletedNCT04979169Not applicable
- the Efficacy and Safety of Anlotinib Combined With Almonertinib in the First-line Treatment of Patients With Brain Metastases From EGFR Mutation-positive Non-small Cell Lung CancerStatus unknownNCT04978753Phase 2
- Adagrasib in Combination With BI 1701963 in Patients With Cancer (KRYSTAL 14)TerminatedNCT04975256Phase 1
- Mobile 3D C-arm CT for Lung Tumor Localization Efficacy Analysis: a Prospective Clinical TrialCompletedNCT04974632Not applicable
- Comparative Effectiveness Analysis of Granulocyte Colony Stimulating Factor Originator Products Versus BiosimilarsCompletedNCT04971304
- A Study of Furmonertinib Combined With Radiotherapy for Non-small Cell Lung Cancer With OligoprogressionStatus unknownNCT04970693Phase 2
- Camrelizumab Combined With Pemetrexed and Carboplatin for the Study of EGFR-mutated Lung Squamous NSCLC TreatmentStatus unknownNCT04970043Not applicable
- Improving Lung Cancer Screening Adherence by Overcoming Barriers for Vulnerable PopulationsCompletedNCT04969341
- Determination and Validation of a Multi-analyte Assay for Lung Cancer ScreeningCompletedNCT04968548
- Application of Pablizumab Combined With Apatinib and Chemotherapy in Resectable Non-small Cell Lung Cancer： A Prospective, Single Arm, Single Center Phase II Clinical Study of Neoadjuvant TherapyStatus unknownNCT04968002Phase 2/3
- A Phase II Study of Sintilimab Combined With Anlotinib in Treatment of ED-SCLCStatus unknownNCT04967625Phase 2
- Trametinib Plus Anlotinib in Non-G12C KRAS-Mutant NSCLC PatientsCompletedNCT04967079Phase 1
- Implementation, Effectiveness and Impact of a Value Based Intervention for Patients with Breast or Lung CancerCompletedNCT04960735Not applicable
- Evaluation of Clinical Significance and Feasibility of CT Guided Biopsy of Double Site Lesions：A Preliminary Lung Centered StudyCompletedNCT04960631
- A Study of Anti-Cancer Therapies Targeting the MAPK Pathway in Patients With Advanced NSCLCCompletedNCT04959981Phase 1
- A Trial of Anlotinib Combined With Concurrent Chemoradiotherapy in Patients With Unresectable Stage III Non-small Cell Lung CancerTerminatedNCT04958993Phase 1/2
- Tiragolumab With Atezolizumab Plus Bevacizumab in Previously-Treated Advanced Non-squamous NSCLCActive, not recruitingNCT04958811Phase 2
- Evaluation of a Novel Microfluidic Device to Purify Metastatic Lung Cancer Patients CTC (Circulating Tumoral Cells)TerminatedNCT04957602
- Ultralow-dose CT for Lung Cancer ScreeningCompletedNCT04957030Not applicable
- Evaluating Modifiable Biomarkers for the Prediction of Immunotherapy Response and ToxicityCompletedNCT04954885
- Fecal Microbial Transplantation Non-Small Cell Lung Cancer and MelanomaActive, not recruitingNCT04951583Phase 2
- Fraction Dose Escalation of Hypo-fractionated Radiotherapy in LANSCLCCompletedNCT04951063Phase 1
- A Study of Camrelizumab Combined With Chemotherapy Sequential Camrelizumab Combined With Apatinib Treatment of Advanced NSCLCStatus unknownNCT04950400Not applicable
- Tribally Engaged Approaches to Lung Screening (TEALS)Active, not recruitingNCT04948060Not applicable
- Prophylactic Cranial Irradiation in Extensive-stage Small Cell Lung CancerStatus unknownNCT04947774
- Decision Aid for the Improvement of Decision-Making in Patients With Non-small Cell Lung CancerActive, not recruitingNCT04946279Not applicable
- MR-Linac Guided Adaptive FSRT for Brain Metastases From Non-small Cell Lung CancerCompletedNCT04946019Phase 2
- Safety and Feasibility of Surgery After Conversion Therapy for Locally Advanced and Advanced NSCLCActive, not recruitingNCT04945928Not applicable
- Neoadjuvant Immune Checkpoint Inhibitor Combined With Chemotherapy in Non-small Cell Lung CancerStatus unknownNCT04945200
- SCION: SABR and Checkpoint Inhibition of NSCLCWithdrawnNCT04944173Phase 2
- Neoadjuvant Immunotherapy and Chemotherapy Followed by Surgery in Unresectable Stage Ⅲ NSCLCStatus unknownNCT04943029Phase 2
- Lung Perfusion PET / CT Using Ga68-MAA for Preservation of Lung Function During Stereotactic Pulmonary Radiation TherapyStatus unknownNCT04942275Phase 2/3
- Neoadjuvant Immunotherapy With Chemotherapy for Stage I-IIIB Non-Small Cell Lung Cancer PatientsStatus unknownNCT04941417Phase 2
- Shared Decision Making on Radiation Dose for Lung MalignanciesActive, not recruitingNCT04940936Not applicable
- UNITO-001- Study in HRR/PDL1 Positive MPM/NSCLCStatus unknownNCT04940637Phase 2
- Datopotamab Deruxtecan (Dato-DXd, DS-1062a) in Advanced and/or Unresectable Non-Small Cell Lung CancerActive, not recruitingNCT04940325Phase 2
- Tocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial CarcinomaActive, not recruitingNCT04940299Phase 2
- Olaparib and Bevacizumab in Relapsed Small Cell Lung Cancer SubjectsCompletedNCT04939662Phase 2
- Molecular Profiling of Exosomes in Tumor-draining Vein of Early-staged Lung CancerCompletedNCT04939324Not applicable
- Real Life Study Evaluating the Clinical and Organisational Impact of Moovcare® Lung Connected Medical Device in Lung Cancer Patients : REAL-MOOV-LUNGCompletedNCT04934865Not applicable
- Fluzopalil in Combination With Anlotinib for Extensive Small-cell Lung CancerStatus unknownNCT04933175Phase 2
- Dose Escalation and Dose Expansion Study of CPO-100 in Patients With Advanced Solid TumorsTerminatedNCT04931823Phase 1
- A Multicentre Study of Intraoperative Body Temperature Changes in Patients Undergoing Thoracoscopic Radical Surgery for Lung CancerCompletedNCT04931589
- Metformin for Chemoprevention of Lung Cancer in Overweight or Obese Individuals at High Risk for Lung CancerActive, not recruitingNCT04931017Phase 2
- Testing the Addition of Radiation Therapy to the Usual Treatment (Immunotherapy With or Without Chemotherapy) for Advanced Stage Non-small Cell Lung Cancer Patients Who Are PD-L1 NegativeActive, not recruitingNCT04929041Phase 2/3
- Charcoal in Lung Cancer Patients Undergoing TEMLAWithdrawnNCT04928950Phase 2
- Design and Evaluation of a Novel Methodology for SABR for Lung CancerStatus unknownNCT04928755
- Understanding Rural Patient and Provide Preferences for Mobile Lung Cancer Screening ClinicsSuspendedNCT04926662
- Magnetic Resonance Guided Adaptive Stereotactic Body Radiotherapy for Lung Tumors in Ultracentral LocationActive, not recruitingNCT04925583Phase 1
- Microbiota Transplant in Advanced Lung Cancer Treated With ImmunotherapyCompletedNCT04924374Not applicable
- Savolitinib for Treating Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) PatientsCompletedNCT04923945Phase 3
- Aumolertinib with or Without Chemotherapy As 1st Line Treatment in Locally Advanced or Metastatic Non-Small Cell Lung Cancer with Sensitizing EGFR MutationsActive, not recruitingNCT04923906Phase 3
- Multi-Omics Testing for Immunotherapy Efficacy Evaluation (MOTIVATION)TerminatedNCT04923802
- Vagus Nerve Preservation and Chronic Cough in Non-small Cell Lung Cancer SurgeryStatus unknownNCT04923412Not applicable
- Educational Intervention for the Promotion of Knowledge and Preventive Health Behaviors Related to Personal Air Pollution Exposure, The Air StudyCompletedNCT04922697Not applicable
- Practical Usability of EGFR Mutation Detection in ctDNA From Resectable NSCLCStatus unknownNCT04922073
- All-Trans Retinoic Acid (ATRA) and Atezolizumab for the Treatment of Recurrent or Metastatic Non-Small Cell Lung CancerCompletedNCT04919369Phase 1
- Immunological Markers Predictive of Response and Toxicity to Checkpoint Inhibitors in Non-small Cell Lung CancerStatus unknownNCT04918836
- Study of LUNG Stereotactic Adaptive Ablative RadiotherapyWithdrawnNCT04917224Not applicable
- A Study to Evaluate Routine Chest Tube Management After Minimally Invasive Lung SurgeryStatus unknownNCT04913415Not applicable
- HANSE - Holistic Implementation Study Assessing a Northern German Interdisciplinary Lung Cancer Screening EffortActive, not recruitingNCT04913155Not applicable
- A Trial of ChAdOx1 and MVA Vaccines Against MAGE-A3 and NY-ESO-1SuspendedNCT04908111Phase 1/2
- Almonertinib Combined With Cerebral Radiation Treat Brain Metastases From EGFR Positive NSCLCStatus unknownNCT04905550Phase 2
- Safety and Long-term Effects of COVID-19 Vaccines in Patients With Pulmonary TumorWithdrawnNCT04894682
- EF-36/Keynote B36: A Pilot, Randomized, Open-label Study of Tumor Treating Fields (TTFields, 150 kHz) Concomitant With Pembrolizumab for First Line Treatment of Advanced or Metastatic Non-small Cell Lung CancerTerminatedNCT04892472Phase 2
- Study of ESG401 in Adults With Solid TumorsCompletedNCT04892342Phase 1/2
- A Phase Ib / IIA Study of AL8326 in Small Cell Lung CancerStatus unknownNCT04890795Phase 1/2